BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15998521)

  • 1. Atorvastatin induces insulin sensitization in Zucker lean and fatty rats.
    Wong V; Stavar L; Szeto L; Uffelman K; Wang CH; Fantus IG; Lewis GF
    Atherosclerosis; 2006 Feb; 184(2):348-55. PubMed ID: 15998521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites.
    Bełtowski J; Atanassova P; Chaldakov GN; Jamroz-Wiśniewska A; Kula W; Rusek M
    Atherosclerosis; 2011 Dec; 219(2):526-31. PubMed ID: 21889144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM
    J Diabetes Complications; 2014; 28(3):323-7. PubMed ID: 24560135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
    Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin prevents type 2 diabetes mellitus--an experimental study.
    Madhu SV; Aslam M; Galav V; Bhattacharya SK; Jafri AA
    Eur J Pharmacol; 2014 Apr; 728():135-40. PubMed ID: 24530420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.
    Bergstrom JD; Bostedor RG; Rew DJ; Geissler WM; Wright SD; Chao YS
    Biochim Biophys Acta; 1998 Jan; 1389(3):213-21. PubMed ID: 9512650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diazoxide enhances adipose tissue protein kinase B activation and glucose transporter-4 expression in obese Zucker rats.
    Alemzadeh R; Zhang J; Tushaus K; Koontz J
    Med Sci Monit; 2004 Mar; 10(3):BR53-60. PubMed ID: 14976464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats.
    Wilkes JJ; Nelson E; Osborne M; Demarest KT; Olefsky JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E617-24. PubMed ID: 15536205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.
    Berthiaume N; Carlson CJ; Rondinone CM; Zinker BA
    Metabolism; 2005 Nov; 54(11):1515-23. PubMed ID: 16253642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats.
    Beha A; Juretschke HP; Kuhlmann J; Neumann-Haefelin C; Belz U; Gerl M; Kramer W; Roden M; Herling AW
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E989-97. PubMed ID: 16380389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific effects of in vivo adenosine receptor blockade on glucose uptake in Zucker rats.
    Crist GH; Xu B; Lanoue KF; Lang CH
    FASEB J; 1998 Oct; 12(13):1301-8. PubMed ID: 9761773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
    Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
    Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate.
    Zhang N; Huan Y; Huang H; Song GM; Sun SJ; Shen ZF
    Acta Pharmacol Sin; 2010 Jan; 31(1):35-42. PubMed ID: 20023693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
    Huptas S; Geiss HC; Otto C; Parhofer KG
    Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats.
    Wheatley CM; Rattigan S; Richards SM; Barrett EJ; Clark MG
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E804-9. PubMed ID: 15213062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.
    Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M
    Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats.
    Zhang X; Deguchi S; Deguchi K; Ohta Y; Yamashita T; Shang J; Tian F; Liu N; Liu W; Ikeda Y; Matsuura T; Abe K
    J Neurosci Res; 2011 Aug; 89(8):1228-34. PubMed ID: 21538457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice.
    Suzuki M; Kakuta H; Takahashi A; Shimano H; Tada-Iida K; Yokoo T; Kihara R; Yamada N
    J Atheroscler Thromb; 2005; 12(2):77-84. PubMed ID: 15942117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.